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Insulin is a key autoantigen in Type 1 Diabetes (T1D), targeted by both T and B cells.
Therefore, understanding insulin-specific T:B cell interactions is important. We have
previously reported an insulin-reactive CD4+ T cell, (designated 2H6). Unlike other
insulin-reactive T cells, 2H6 cells protect non-obese diabetic (NOD) mice from T1D
development, mediated by TGFb. To investigate insulin-specific T:B cell interactions,
we bred 2H6ab T cell receptor transgenic NOD mice (2H6) with the insulin-reactive B cell
receptor transgenic NOD mice (VH125), generating 2H6VH125 NOD mice. Similar to 2H6
mice, 2H6VH125 mice are protected from T1D development. Interestingly, VH125 B cells
did not alter the phenotype of 2H6 T cells; however, 2H6 T cells significantly altered the
VH125 B cells by reducing the insulin-reactive non-germinal center (GC) and GC B cells,
as well as MHC and costimulatory molecule expression on the B cells. Furthermore, the B
cells in 2H6VH125 NOD mice exhibited increased non-insulin-specific and a class
switched IgG isotype, which can be recapitulated in vivo in Rag-deficient NOD mice by
adoptive transfer. In vitro, VH125 B cells from 2H6VH125 mice suppressed the
proliferation of 2H6 T cells to insulin antigen but enhanced TGFb secretion by 2H6 T
cells from 2H6VH125 mice compared to 2H6 mice. In summary, our data showed that
2H6 CD4+ T cells alter the phenotype and function of insulin-reactive B cells from
pathogenic to tolerogenic cells. In turn, VH125 B cells also modulate the function of the
2H6 T cells. Thus, promoting the interactions between antigen-specific regulatory T cells
and B cells may lead to protection from T1D.
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Insulin is known to be a major autoantigen contributing to the
development of Type 1 diabetes (T1D) in both humans (1–5)
and Non-obese diabetic (NOD) mice (6–10). This autoantigen is
recognized by CD4+ (6, 8) and CD8+ (3, 9) T cells, and B cells
(11, 12). Furthermore, the second most important gene
determining susceptibility to T1D in humans (IDDM2)
influences the level of proinsulin expression in the thymus (13,
14). Graded deficiency in insulin gene copy numbers leads to a
higher proportion of insulin-reactive T cells escaping thymic
negative selection in C57BL/6 mice (15) and these cells cause
accelerated diabetes in NOD mice (10).
Several insulin-reactive T cell clones are pathogenic (3, 6, 9,
16–18), whereas the 2H6 T cell clone, isolated from the islets of
NOD mice is regulatory and protects mice from T1D
development, mediated by TGFb (8, 19). 2H6 recognizes
overlapping Insulin B chain peptides 12–25 and 9–23, a core
sequence shared by insulin-reactive pathogenic T cell clones (7,
9). Interestingly, mutating the tyrosine to alanine at position 16
of the insulin B chain prevented antigen recognition by
pathogenic insulin-reactive CD4+ and CD8+ T cells and
protected NOD mice from developing diabetes (10, 20, 21),
demonstrating the importance of this B chain region of insulin
in T1D development.
Anti-insulin autoantibodies have been an important
biomarker for prediction and diagnosis of T1D development in
humans (22–25). Insulin-reactive B cells in NOD mice can also
alter the development of T1D (12). B cell receptor (BCR)
transgenic mice with a fixed IgM heavy chain, VH125, known
to bind to insulin, increased the population of insulin-specific B
cells in NOD mice but not in non-autoimmune prone C57BL/6
mice (11, 12). To address the role of class-switching on VH125 B
cells, Williams and co-authors generated C57BL/6 mice
expressing VDJH-125 site-directed to the native IgH locus
(VH125SD) (26). The B cells in these mice exhibited impaired
proliferation to insulin and failed to produce IgG antibodies
upon insulin immunization; however, this could be overcome
when both BCR and toll-like receptors (TLRs) were stimulated
simultaneously. Using a double transgenic Rag-/-NOD mouse
model that expresses the T cell receptor (TCR) of the pathogenic
insulin B12-20-reactive CD4+ T cell (8F10) and the VH125 BCR,
Wan and colleagues demonstrated that the presence of insulin-
reactive pathogenic CD4 T cells enables the class switching
(VH125SD) of VH125 B cells (27). Using this model, the
authors also demonstrated insulin-specific T:B cell interactions
(27). 8F10 VH125SD mice have increased anti-insulin germinal
center B cells and can undergo IgG class switching when both the
T cells and B cells are antigen-restricted. However, the role of
regulatory insulin-specific T cells in modulating insulin-reactive
VH125 B cells is still unknown. To fill this knowledge gap, we
generated 2H6VH125 NOD mice encompassing the 2H6 TCR
and heavy chain of 125 BCR transgenes.
Our study revealed that the presence of 2H6 T cells not only
reduced the proportion of insulin-reactive B cells, but also
reduced insulin binding to the B cells. Moreover, the presenceFrontiers in Immunology | www.frontiersin.org 2of 2H6 T cells decreased the ability of B cells to present the
antigen to insulin-reactive T cells. Interestingly, in the presence
of VH125 B cells, 2H6 T cells had significantly enhanced TGFb
secretion but reduced proliferation in response to antigen
stimulation in vitro compared to the 2H6 T cells that
developed in the absence of VH125 B cells. Furthermore, the
presence of both insulin-reactive TCR and BCR lowered the
proportion of germinal center (GC) B cells and the expression of
PDL1-PD1molecules, particularly in the pancreatic lymph nodes
(PLNs). We also found that some of the VH125 B cells in the
2H6VH125 NOD mice underwent IgG class switching, unlike
VH125 B cells from VH125 NOD mice. Our data suggest that
2H6 T cells regulate their interactions with the insulin-specific B
cells and alter the pathogenic VH125 B cells to favor TGFb
production by 2H6 T cells, and thus, mediate diabetes protection.
Therefore, modulating antigen-specific T:B cell interactions may
be of benefit in optimizing antigen-specific therapies, to promote
protection and minimize autoimmunity.MATERIALS AND METHODS
Mice
NOD/Caj mice were originally obtained from the Jackson
Laboratory and have been maintained at Yale University for
over 30 yrs. 2H6TCRab NOD mice (designated 2H6; expressing
the TCRa chain Va6/Ja45/Ca and the TCRb chain Vb14/Db1.1/
Jb2.3/Cb2) were generated, as previously described (8, 19), and
maintained at Yale University. VH125 NODmice, expressing the
heavy chain of the insulin-reactive monoclonal antibody (mAb)
125 were generated by Dr James Thomas (Vanderbilt University)
(12) and obtained from the Jackson Laboratory (Bar Harbor,
Maine). Approximately >95% of these VH125 B cells were IgMa,
indicating a high level of allelic exclusion (data not shown).
2H6VH125 NOD mice were obtained by breeding 2H6 NOD
mice with VH125 NOD mice. Recombinase-activating-gene
deficient NOD (Rag-/-NOD) mice were originally obtained
from the Jackson Laboratory and maintained at Yale
University. All the mice used in this study were kept in specific
pathogen–free (SPF) conditions, in a 12-hour dark/light cycle
and housed in individually-ventilated filter cages with free access
to water and autoclaved food at the animal facility of Yale
University. The Yale University Institutional Animal Care and
Use Committee approved the usage of animals and the
procedures used in this study.
Diabetes Monitoring
Mice were monitored for glycosuria, from 12-weeks of age, for
spontaneous diabetes development, with diabetes confirmed
with a blood glucose >250 mg/dl.
Histology
Pancreata from 12-week-old female mice were collected and
formalin-fixed. Sections from 2–3 different layers within each
pancreata were cut and haemotoxylin and eosin stained. Islets
were scored under light microscopy by a blinded scorer.November 2020 | Volume 11 | Article 585886
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Single cell suspensions were prepared from splenocytes and
pancreatic lymph nodes (PLNs) harvested from 8-week-old
mice. Cells were incubated with Fc block (2.4G2) for 10 min at
room temperature prior to mAb staining and a cell viability dye
(Zombie Aqua Fixable viability dye, BioLegend) for 30 min at 4°C.
All the antibodies used in this study were from Biolegend and
diluted 1:400 to 1:500 unless otherwise stated. T cells were stained
with mAbs to CD4 (GK1.5), CD25 (PC61), CD69 (H1.2F3), PD1
(29F.1A12), CD8a (53-6.7), CD40L (MR1), CXCR5 (L138D7),
CCR7 (4B12), and TCR Vb14 (14-2; BD Biosciences). B cells were
stained with mAbs to CD19 (6D5), B220 (RA3-6B2), MHCII (10-
3.6), CD40 (3/23), CD21 (7E9), CD23 (B3B4), GL7 (GL7), CD80
(16-10A1), CD86 (GL-1), PDL-1 (10F.9G2), and PNA (Sigma).
Insulin-FITC (Sigma) was used for the detection of insulin-
reactive B cells (at a dilution of 1:2000) as previously described
(28). Cells were then washed (with an additional wash if stained
with insulin-FITC), resuspended and examined on a BD LSRII
flow cytometer on the same day. Fluorescence minus one (FMO)
controls were used in the initial compensation and all the cells
were gated on single live cells. Data were analyzed with Flowjo
version 8.8.6 (Treestar).
Insulin Auto-Antibody Measurements by
Sandwich ELISA
Peripheral blood from 8-week-old donor mice was collected and
kept at 4°C for 4 h to clot, prior to serum separation by
centrifugation (8000rpm, 5 min, room temperature). 96-well
plates were coated with 4 mg/ml insulin (Humulin N, Lilly)
overnight at 4°C, followed by washing with PBS (0.05%
TWEEN). The plates were then blocked with PBS containing
1% BSA, for 1 hour at room temperature. After an additional
wash, diluted sera (1:100) were added to the plates and incubated
for 2 h at room temperature. Post-wash, alkaline phosphatase
(AP)-conjugated Ig, IgG or IgM (1:1000, Southern Biotech) was
added for a further 2 h incubation at room temperature. After
washing, PNPP substrate (Sigma) was added. The enzymatic
reaction was stopped using 1M NaOH. Plates were read at
OD405 using a microplate spectrophotometer (Perkin Elmer)
and data were plotted, based on the optical density (OD) values.
Measurement of Total Immunoglobulins
(Ig) and Different Isotypes by Direct ELISA
Serum samples were prepared and diluted as described above and
used to coat the plate overnight at 4°C. Known concentrations of
Ig or isotypes were also coated for standard curves. The plates were
washed and blocked the next day, prior to the addition of pre-
titrated Ig-AP, IgG-AP or IgM-AP. The ELISA was completed by
enzymatic reaction using PNPP substrate (see above). The plates
were read at OD405 using a microplate spectrophotometer
(Perkin Elmer) and sample concentrations were determined
using standard curves for each isotype.
Cytokine Measurements by ELISA
Cell culture supernatants and/or sera were assessed for TGFb1
(Mouse TGFb1 DuoSet ELISA, R&D Systems) and IL-21 (MouseFrontiers in Immunology | www.frontiersin.org 3IL-21 ELISA Ready-SET-GO! Kit, eBioscience) following the
manufacturers’ protocols.
Cell Isolation
B cells and CD4+ T cells were isolated from the spleen of 8-week-
old donor mice. B cells were purified by negative selection using
the EasySep Mouse B cell Isolation kit (StemCell Technologies).
Splenic CD4+ T cells were purified using hybridoma
supernatants containing mAbs to CD8 (TB105) and I-Ag7
(10.2.16, recognizing MHC class II I-A of NOD mouse),
generously provided by the late Charles Janeway Jr. (Yale
University) for 30 min at 4°C. Cells were then washed in PBS
and incubated for 45 min on ice with magnetic beads conjugated
with goat anti-mouse IgG, goat anti-mouse IgM, or goat anti-rat
IgG (QIAGEN). CD4+ T cells were magnetically isolated using
negative selection. The purity for all cells was 95–99% as verified
by flow cytometry.
qPCR
Total RNA was extracted from purified splenic B cells (see above)
of 8-week-old donor mice using the RNeasy Mini Kit (Qiagen),
prior to cDNA generation with the iScriptTM cDNA synthesis kit
(Bio-Rad). The transcriptional levels of genes of interest were
detected by qPCR on an iCycler (Bio-Rad). qPCR data were
presented as fold change using the 2-DDCt method and
normalized with the GAPDH values. Primer sequences: aicda
(F- 5’CCTAAGACTTTGAGGGAGTCAA3’, R- 5’CACGTAG
CAGAGGTAGGTCTC3’), tgfbetar1 (F- 5’TCACATTGTG
CCAATGGAAT3’, R- 5’AAAATTGCAAACCTGGTGGA3’),
il6 (F- 5’CCAGAGATACAAAGAAATGATGG3’, R- 5’ACTCC
AGAAGACCAGAGGAAAT3’), and gapdh (F- 5’AGGTCGGTG
TGAACGGATTTG3’, R-5’GGGGTCGTTGATGGCAACA3’).
Cell Proliferation
Purified CD4+ T cells and B cells were co-cultured at 1:1 ratio, in
the presence of insulin B chain 12–25 peptide or denatured
insulin (heat inactivated at 95°C for 5 minutes) for 48 h. Culture
supernatants were collected prior to the addition of 3H-
thymidine and the cells were cultured for a further 18 h. Cell
proliferation was assessed by 3H-thymidine incorporation,
quantified by a b counter. Data were normalized as corrected
CPM whereby the background (cultures without antigen)
was subtracted.
Adoptive Transfer
Four-week-old Rag-/-NOD mice were infused (i.v.) with 3x106
purified CD4+ T cells, together with the same number of purified
B cells (1:1 ratio). Recipient mice were harvested for experiments
4 weeks post-transfer.
Statistics
Multiple Student’s t tests with FDR correction were used to
determine the statistical significance for all the results presented,
except Supplementary Figure 1 where a Log-rank (Mantel-Cox)
test and chi-square test was used and Figure 4A where two-way
ANOVA was used. Statistical analysis was conducted using
Prism 8.November 2020 | Volume 11 | Article 585886
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The Presence of Insulin-Reactive VH125
BCR Does Not Affect the Phenotype of
Insulin-Reactive 2H6 T Cells
To investigate the interaction of insulin-reactive regulatory T
cells with B cells, we bred 2H6ab TCR transgenic NOD mice
(2H6) with VH125 BCR transgenic mice (VH125) to generate
2H6abVH125 transgenic NOD mice (2H6VH125). 2H6 NOD
mice are protected from T1D development (19) whereas VH125
NOD mice have accelerated T1D development (12). We
hypothesized that 2H6VH125 mice would have a reduced
incidence of diabetes. To test our hypothesis, we monitored
incidence of diabetes in these mice. Interestingly, 2H6VH125
mice were completely protected from diabetes development,
similar to 2H6 NOD mice (Supplementary Figure 1A).
Furthermore, like 2H6 mice, there was minimal evidence of
insulitis in the 2H6VH125 NOD mice (Supplementary Figure
1B). To determine the impact of the VH125 B cells on the T cellFrontiers in Immunology | www.frontiersin.org 4compartment in the 2H6VH125 mice, we examined the
phenotype of T cells in different lymphoid tissues. We found
that 2H6VH125 NOD mice had reduced splenic cellularity,
although there were no differences in cellularity of the PLNs
compared to both the parental TCR and BCR transgenic NOD
mice (Supplementary Figure 2A). Mesenteric lymph nodes and
Peyer’s Patches were also harvested and found to have similar
trends (data not shown). The expression of the 2H6 TCR
transgene, with or without the co-expression of the VH125
BCR, led to significant increases in the proportion of CD4+ T
cells in the PLN compared to non-transgenic NOD mice and
VH125 NODmice (Figure 1A). As expected, in the parental 2H6
TCR transgenic mice, the majority of the T cells were 2H6
transgenic TCRVb14+, the surrogate marker for clonotypic
2H6 TCR, and the expression of VH125 BCR had no effect on
the selection of these TCRVb14+ T cells (Figure 1B). However,
the intensity of TCR expression, presented as mean fluorescence
intensity (MFI), was reduced in transgenic 2H6 T cells compared
to the non-transgenic TCRVb14+ cells (Figure 1C), whichA B D
E F G
I
H
C
FIGURE 1 | VH125 BCR transgene does not influence 2H6 T cell phenotype. Splenocytes and cells from the pancreas draining lymph nodes (PLN) were harvested
from 8-week-old mice and stained using antibodies for flow cytometry. (A) % of live single CD4+CD8-CD19- T cells. (B, C) % and mean fluorescent intensity (MFI) of
TCRVb14+ (the TCRVb chain used in the 2H6 TCR transgene) in CD4+ T cells gated from (A). (D–G) % of CD4+CD25+ T cells and CD4+CD69+ T cells gated on
total CD4+ T cells and CD4+ TCRVb14+. (H–I; % of CD4+CD40L+ T cells gated on total CD4+ T cells and CD4+ TCRVb14+. Data were generated from 9 to 10
individual mice pooled from 4 to 5 independent experiments. Data from left to right: NOD, 2H6, VH125, and 2H6VH125 are shown in this order in each plot. Data
from NOD mice are shown as a non-transgenic mouse comparison. Data were assessed for significance using multiple T tests and FDR correction. **P < 0.001,
***P < 0.0001.November 2020 | Volume 11 | Article 585886
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polyclonal NOD [Figure 1B and (19)] and VH125 mice (Figure
1B). Furthermore, the expression of the 2H6 TCR transgene
reduced the T cell activation, particularly in the PLNs, as
demonstrated by the reduced proportion of CD25 and CD69 in
both the total CD4+ T cells (Figures 1D, E) and the TCRVb14+
CD4Tcell population (Figures 1F,G) compared towild-typeNOD
and VH125 mice, which express polyclonal TCRs. Finally, we
analyzed the expression of CD40L, an important ligand for T:B
cell interactions and B cell maturation, and found reduced CD40L
on theCD4+T cells in the 2H6-expressingmice compared toNOD
and VH125mice (Figures 1H–I). Interestingly, CD40L expression
on CD4+TCRVb14+ T cells in VH125 NOD mice, but not
2H6VH125 NOD mice, was increased, suggesting that non-2H6-
restricted TCRVb14-expressing CD4+ T cells may provide more
costimulation to the B cells in VH125 NOD mice (Figure 1I).
However, the insulin-reactive BCR does not appear to promote the
activation of the insulin-reactive 2H6 T cells in the 2H6VH125
NOD mice , which may contr ibute to the disease-
protected phenotype.Frontiers in Immunology | www.frontiersin.org 5Insulin-Reactive 2H6 TCR Inhibits the
Insulin-Reactive B Cell Populations and
Alters B Cell Phenotype
Although the presence of the insulin-reactive B cells did not
appear to have substantial effects on the 2H6 cells, we asked
reciprocally whether the changes in T cells, as a result of TCR
transgene expression, affected B cell development. This was
particularly related to the finding of the reduced proportion of
CD40L+ T cells in 2H6 and 2H6VH125 NOD mice. To test our
hypothesis, we examined the B cell compartment in the four
strains of NOD mice. Interestingly, we found that both VH125
and 2H6VH125 NOD mice had reduced CD19+B220+ B cells
compared to NOD and 2H6 NOD mice (Figure 2A). Next, we
studied the impact of the 2H6 TCR on the insulin-specific B cells.
We demonstrated that the 2H6 TCR significantly reduced the
insulin-reactive B cells in 2H6VH125 NOD mice compared to
VH125 BCR transgenic mice, even though the proportion and
number of these insulin-reactive B cells was still higher than in
NOD and 2H6 NOD mice (Figures 2B, C and Supplementary
Figures 2B, C). However, the VH125 BCR expression reducedA B D
E F G H
C
FIGURE 2 | The 2H6 TCR transgene strongly reduces frequency of insulin-reactive VH125 B cells and their costimulatory molecule expression. Splenocytes and
cells from the pancreas draining lymph nodes (PLN) were harvested from 8-week-old mice and stained using antibodies for flow cytometry. (A) % of live single
CD19+B220+TCRb- B cells. (B) % of insulin-reactive B cells identified by binding to insulin-FITC in CD19+B220+ B cells gated from (A). (C) Absolute number of
Insulin-reactive B cells. (D, E) Mean fluorescent intensity (MFI) of insulin-FITC and MHCII (IAg7), gated within the insulin-reactive B cells in (B). (F–H) % of CD40,
CD80, and CD86 gated within the insulin-reactive B cells. Data were generated from 10 individual mice pooled from 4 to 5 independent experiments. Data from left
to right: NOD, 2H6, VH125, and 2H6VH125 are shown in this order in each plot. Data from NOD mice are shown as a non-transgenic mouse comparison. Data
were assessed for significance using multiple T tests and FDR correction. **P < 0.001, ***P < 0.0001.November 2020 | Volume 11 | Article 585886
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zone B cells in both VH125 BCR and 2H6VH125 transgenic
mice (Supplementary Figures 2D, E), supporting an earlier
report (29). Further investigation of the insulin-reactive B cells
revealed reduced insulin binding to the insulin-reactive B cells in
2H6VH125 NOD mice compared with VH125 transgenic mice
(Figure 2D). The presence of 2H6 TCR also led to the reduced
expression of MHCII on the surface of insulin-reactive B cells
isolated from both 2H6 and 2H6VH125 NOD mice (Figure 2E).
MHCII expression was also significantly reduced on the total B
cell population in 2H6VH125 NOD mice (Supplementary
Figure 2F). Moreover, the presence of the 2H6 transgene
reduced the expression of costimulatory molecules (CD40,
CD80, CD86) on the insulin-reactive B cells compared to
VH125 NOD mice (Figures 2F–H). This effect was also noted
on the total B cell population (Supplementary Figures 2G–I).
Therefore, the presence of the 2H6 T cell transgene has profound
effects on both the T cell and B cell phenotype, promoting a more
tolerogenic environment in vivo.Frontiers in Immunology | www.frontiersin.org 6Insulin-Reactive T Cells Induce the Insulin-
Reactive B Cells to Undergo Non-Insulin-
Specific Class Switching
Next, we determined whether expression of the insulin-reactive
TCR affects the B cell secretion of polyclonal immunoglobulins
(Igs). Expression of the 2H6 TCR alone did not affect the levels of
total Igs or different isotypes of Ig compared with wild-type NOD
mice (Figures 3A–C). However, expression of the VH125 BCR
significantly reduced total circulating Ig (Figure 3A), and IgG
(Figure 3B) compared with wild type NOD and 2H6 TCR
transgenic mice. In contrast, expression of VH125 significantly
enhanced IgM production (Figure 3C), which was expected, as
VH125 BCR encodes an IgM isotype antibody. However, it is
interesting that co-expression of 2H6 TCR and VH125 BCR
altered the ability of some B cells to secrete other isotypes of Ig
including IgG, (Figures 3A, B and Supplementary Figures 3A–
C) but suppressed IgM production by VH125 B cells (Figure
3C). Interestingly, serum IgA was significantly increased in all
the transgenic mice compared to the non-transgenic NOD miceA B D
E F G
I
H
C
FIGURE 3 | 2H6 TCR transgene promotes IgG class switching in VH125 B cells. (A–F) Sera from 8-week-old mice were tested for total Ig (A), IgG (B), IgM (C), and
insulin-specific autoantibodies of the same isotypes (D to F). RNA from splenic B cells was isolated and cDNA synthesized, prior to performing qPCR, to quantify the
aicda (G), tgfbeta1 (H), and il6 (I) genes. qPCR data are presented as fold change using the 2-DDCt method and normalized using the GAPDH values. Data were
generated from 9 to 10 individual mice pooled from two independent experiments. Data from left to right: NOD, 2H6, VH125, and 2H6VH125 are shown in this order
in each plot. Data from NOD mice are shown as a non-transgenic mouse comparison. Data were assessed for significance using multiple T tests and FDR
correction. **P < 0.001, ***P < 0.0001.November 2020 | Volume 11 | Article 585886
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reactive TCR modified the polyclonal antibody production by
VH125 B cells, we hypothesized that insulin-specific antibodies
would also be affected. To test this, we assessed anti-insulin
antibodies in the serum of the NOD mice, with and without
insulin-reactive TCR and/or BCR. We found that 2H6VH125
NOD mice had the lowest concentration of total anti-insulin-Ig
(Figure 3D), which is in sharp contrast to the total circulating Igs
(Figure 3A). Interestingly, while the 2H6 TCR alone promoted
insulin-specific IgG production by polyclonal B cells compared
to all other mice (Figure 3E), expression of VH125 alone resulted
in increased insulin-specific IgM production, as anticipated
(Figure 3F). Further investigation into IgG subclasses revealed
that the 2H6VH125 mice had the most decreased insulin-specific
IgG1, while insulin-specific IgG2a and IgG2b were increased
compared to VH125 mice (Supplementary Figures 3E–G).
However, 2H6 mice had the highest concentration of anti-
insulin IgG antibodies (Figure 3E), of IgG2a and IgG2b
isotypes (Supplementary Figures 3F–G). The presence of the
2H6 transgene only, in the T cells, which recognize insulin,
increased insulin-specific B cell autoantibodies, potentially due to
the increased frequency of insulin-reactive T cells; however,
despite this, the T cell-mediated protection is dominant. This
may suggest that anti-insulin autoantibodies can be induced by
both pathogenic and regulatory mechanisms. We also observed
increased anti-insulin IgA in all the transgenic strains compared
to the wild type NOD (Supplementary Figure 3H). To verify the
observed class switching in B cells from 2H6VH125 NOD mice,
we evaluated the gene expression of aicda, encoding an enzyme
required for mediating class switching (30), as well as genes
related to cytokines involved in class switching by qPCR. We
found that B cells from 2H6VH125 mice had increased
expression of aicda, tgfbetar1 and il6 compared to B cells from
VH125 NOD (Figures 3G–I), demonstrating the potential for
enhanced class switching. Our data also suggest the altered
cytokine milieu may promote IgM to IgG class switching in
the 2H6VH125 NOD mice.
2H6 TCR Reduces Antigen Presentation
Function of B Cells While Enhancing TGFb
Secretion
Having identified that insulin-reactive 2H6 T cells suppressed
insulin-reactive B cell production of anti-insulin antibodies, we
asked if 2H6 T cells also modulate the antigen presentation
function of insulin-reactive B cells. To answer this question, we
investigated 2H6 T cell responses to insulin antigen presented by
B cells from i) 125 transgenic (125tg) NOD mice, which express
both light and heavy chains of 125 BCR; ii) VH125 NOD mice,
which express only the heavy chain of 125 BCR and iii)
2H6VH125 NOD mice, which express only the heavy chain of
125 BCR and the 2H6 TCR, iv) 2H6 NOD mice, which have
polyclonal BCR and v) wild type NOD mice, which have
polyclonal BCR. To prevent possible bioactivity of insulin on
the cultured cells, we used heat-denatured insulin. We found that
2H6 CD4+ T cells responded best to the denatured insulin
antigen presented by the 125 B cells. This was followed byFrontiers in Immunology | www.frontiersin.org 7VH125 B cells. Interestingly, B cells from 2H6VH125 NOD
mice had the least capacity to induce proliferation of 2H6 T cells
at the antigen concentration that induced a higher response by
other B cells (3 mg/ml, Figure 4A), although this improved at a
higher insulin concentration (10 mg/ml, Figure 4A). Similar
patterns were also seen when 2H6 CD4+ T cells from
2H6VH125 mice were cultured with B cells from the 5
different mouse strains in the presence of denatured insulin
protein (Figure 4B). Furthermore, 2H6 T cells from 2H6 NOD
mice appeared to have a greater proliferative response to antigen
(higher D CPM) compared with the 2H6 cells from 2H6VH125
mice. This was particularly evident when B cells from 125 mice
were used as antigen presenting cells (APCs) (Figure 4A
compared with Figure 4B). To further confirm the antigen
specificity, we examined the response of 2H6 T cells from 2H6
or 2H6VH125 mice to insulin B chain 12–25 peptide presented
by B cells isolated from the 5 different NOD mouse strains.
Similar to the proliferative response to denatured insulin protein,
the CD4+ T cells from 2H6 NOD mice proliferated more
strongly to the peptide (Figure 4C, higher D CPM) compared
with the 2H6 CD4+ T cells from 2H6VH125 NOD mice (Figure
4D) when B cells from 125 NODmice were used as APCs. Again,
the B cells from 2H6VH125 NODmice showed the lowest ability
to induce proliferation of 2H6 CD4+ T cells (Figures 4C, D).
Given that diabetes protection by 2H6 T cells is mediated
through TGFb (19), we hypothesized that the weaker T cell
proliferative response could be due to a stronger TGFb-induced
immune response. Indeed, we found that TGFb production in
the supernatants of the above cell cultures was highest in the
CD4+ T cell culture supernatants when 2H6VH125 NOD mice
were responders (Figures 4E–H). Furthermore, the highest levels
of TGFb secretion from the 2H6VH125 cell cultures in response
to insulin peptide occurred at the antigen concentration that
induced lower CD4+ T cell proliferation compared to the CD4+
T cells from the other mouse strains. This may suggest that the
low proliferative response of CD4+ T cells from 2H6VH125
NOD mice is likely to be a result of high TGFb production.
2H6 TCR Alters Germinal Center T:B
Interactions
We have shown that 2H6 TCR promoted class switching of
polyclonal B cells but inhibited anti-insulin antibody production
and antigen presentation by insulin-reactive B cells (Figure 3
and Supplementary Figure 2). These results provide strong
evidence that insulin-reactive T cells interact with insulin-
reactive B cells. We, therefore, hypothesized that the germinal
center (GC) reaction, which shapes the development of
specialized GC B cell and follicular helper T cell (Tfh) immune
responses in vivo (31, 32), is also affected. To test our hypothesis,
we first examined GC B cells, characterized by PNA and GL7
dual expression, in the spleen and PLN. We found that the
expression of VH125 sharply increased the proportion of total
GC B cells in VH125 and 2H6VH125 mice compared to NOD
and 2H6 NOD mice, which do not express insulin-reactive BCR
transgenes; however, the co-presence of the 2H6 TCR in
2H6VH125 mice led to a lesser increase of the GC B cellsNovember 2020 | Volume 11 | Article 585886
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B cells revealed that this lesser increase seen, induced in the
2H6VH125 mice, was also clearly seen in the insulin-specific GC
B cells, especially in PLN (Figure 5C). As PDL1 on B cells, is an
important molecule that regulates Tfh-mediated autoimmunity
(33), we examined expression of PDL1 on the B cells of the
different mouse strains. Expression of 2H6 alone did not have an
obvious effect on PDL1 expression on B cells, whereas the
presence of VH125 markedly increased PDL1-expression on B
cells (Figure 5D). Again, the presence of 2H6 TCR suppressed
PDL1 expression in total and insulin-specific B cells in
2H6VH125 mice compared with these B cells in VH125 mice
(Figures 5D, E). However, the percentage of PDL1+ B cells was
still significantly higher in 2H6VH125 NOD mice compared
with the NOD and 2H6 NOD mice (Figures 5D, E). Next, we
investigated the Tfh cells, characterized by expression of CCR7
and CXCR5, in the 4 NOD mouse strains. We found that 2H6-
expressing mice had more Tfh cells than NOD mice (Figure 5F),
suggesting the increase was related to the 2H6 TCR. Both 2H6
and 2H6VH125 mice had increased Tfh cells compared to
VH125 mice, when assessed by a two-tailed T test, but this did
not reach significance after multiple T test and FDR corrections
were applied. Interestingly, when examining TCRVb14-specificFrontiers in Immunology | www.frontiersin.org 8Tfh cells, we found that NOD and VH125 mice, which do not
express 2H6 TCR, had a higher number of TCRVb14+ Tfh cells,
especially in the PLN (Figure 5G). Next, we investigated the
expression of PD1, the receptor for PDL1, on total CD4+ T cells
and TCRVb14+ T cells. It is interesting that expression of the
VH125 BCR increased the number of PD1+ total and TCRVb14+
CD4+Tcells (Figures 5H, I) inVH125mice,whereas expressionof
the 2H6 TCR reduced PD1 expression, especially in 2H6VH125
NODmice (Figures 5H, I). IL-21, produced by Tfh cells (34), is an
important cytokine for GC formation (35), and we found that
2H6VH125 NOD mice had the lowest level of circulating IL-21
among the 4 mouse strains (Figure 5J), which is in line with the
lowest proportion of Tfh cells (Figures 5G–I). Thus, the reduction
of GC B cells in 2H6VH125 NOD mice is potentially due to the
reduced IL-21, in addition to reduced interactions between the Tfh
cells and GC B cells via the PD1 and PDL-1 pathway.Co-Transfer of 2H6 T Cells and VH125 B Cells to
Rag-Deficient NOD Mice Recapitulates the Cellular
Phenotypes of 2H6VH125 NOD Mice In Vivo
To confirm our in vitro findings in an in vivo setting, we co-
transferred CD4+ T cells from NOD or 2H6 NOD mice togetherA B D
E F G H
C
FIGURE 4 | 2H6 TCR transgene strongly reduces antigen presentation by insulin-reactive VH125 B cells and increases anti-inflammatory TGFb secretion. Splenic B
cells were negatively isolated and cultured with bead-purified CD4+ T cells from 8-week-old mice in a 1:1 ratio. Cells were co-cultured with denatured insulin or
insulin B chain 12-25 peptide at various concentrations for 48 h prior to supernatant collection and 3H-thymidine addition. Proliferation was measured by 3H-
thymidine incorporation and plotted as DCPM, where the background CPM (cells without antigen) was subtracted from the CPM of cells with antigen. (A, B) 2H6
CD4+ T cells isolated from 2H6 NOD mice (A) or 2H6 T cells isolated from 2H6VH125 NOD mice (B) co-cultured with B cells from various donors and denatured
insulin. (C, D) 2H6 CD4+ T cells isolated from 2H6 NOD mice (C) or 2H6 T cells isolated from 2H6VH125 NOD mice (D) co-cultured with B cells from various
donors and insulin B chain 12–25 peptide. (E–H) TGFb measurements from the supernatants of the respective cultures in (A–D). Data were generated from three
independent experiments (n = 2–3 mice/experiment). Data from NOD mice are shown as a non-transgenic mouse comparison. Data were assessed for significance
using two-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.0001.November 2020 | Volume 11 | Article 585886
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deficient NOD mice. We investigated the above phenotypes in
the recipients, 4 weeks post-transfer. We found that the Rag-
deficient mice that were infused with VH125 B cells with 2H6
CD4+ T cells had reduced insulin-specific B cells compared to
the mice receiving VH125 B cells and NOD CD4+ T cells (Figure
6A). In addition, we found that the Rag-deficient recipients
transferred with both 2H6 CD4+ T cells and VH125 B cells
had reduced insulin-specific GC B cells, particularly in the PLN
compared to all other groups (Figure 6B). Similar to the ex-vivo
results shown in Figure 5, we found reduced PDL1+ insulin-
specific B cells in the Rag-deficient recipients that were co-
transferred with 2H6 CD4+ T cells and VH125 B cells
compared to the recipients that received NOD CD4+T cells
and VH125 B cells (Figure 6C). Moreover, the Rag-deficient
recipients that were co-transferred with 2H6 CD4+ T cells andFrontiers in Immunology | www.frontiersin.org 9VH125 B cells had reduced co-stimulatory molecules on the
insulin-specific B cells (Figures 6D–F). All of these observations
mirror our findings from the in vitro experiments. Although the
total concentration of IgG was not the lowest (Figure 6G), the
level of insulin-reactive IgG antibodies was the lowest in the Rag-
deficient recipients co-transferred with 2H6 CD4+ T cells and
VH125 B cells compared to all the other groups (Figure 6H).
Again, total IgG2a and IgG2b isotypes were also increased in the
recipients of co-transferred 2H6 T and VH125 B cells compared
to NOD T and VH125 B cells, while insulin-reactive IgG1
antibodies were lower but insulin-reactive IgG2b were higher
between these co-transferred groups (Supplementary Figure 4).
The presence of IgG in Rag-deficient recipients that received
VH125 B cells in the adoptive transfer model system provides
further evidence that the 2H6 CD4+ T cells can induce isotype
switching in the VH125 B cells (Figure 6G).A B
D E F
G IH J
C
FIGURE 5 | 2H6 TCR transgene alters germinal center interactions in vivo. Splenocytes and cells from the pancreas draining lymph nodes (PLN) were harvested
from 8-week-old mice and stained using antibodies for flow cytometry. (A) Representative flow plots showing PNA vs. GL7 staining of CD19+B220+ B cells, gated
from live single TCRb- cells with summary (B). (C) Insulin-reactive germinal center B cells % [gated as (B) on Insulin+CD19+B220+ B cells]. (D)%CD19+B220+PDL1+ B
cells gated as in (B) and insulin-reactive CD19+B220+PDL1+ B cells (E). (F, G)% of live single CD4+CD8-CD19-CXCR5+CCR7+ T cells gated on total CD4+ T cells (F) and
TCRVbeta14+ CD4+ T cells (G). (H, I)% of live single CD4+CD8-CD19-PD1+ T cells gated on total CD4+ T cells (H) and TCRVbeta14+ CD4+ T cells (I). IL21 was
measured in sera from 8-week-old mice by ELISA (J). Data were generated from 9 to 10 individual mice pooled from 4 to 5 independent experiments. Data from left to right:
NOD, 2H6, VH125, and 2H6VH125 are shown in this order in each plot. Data from NODmice are shown as a non-transgenic mouse comparison. Data were assessed for
significance using multiple T tests and FDR correction. **P < 0.001, ***P < 0.0001.November 2020 | Volume 11 | Article 585886
Pearson et al. Insulin-Reactive T-Cells Reduce T:B-Cell InteractionsUnlike the ex-vivo results shown in Figure 5, we did not find
any changes in the proportion or phenotype of the Tfh cells in
the in vivo experimental setting (data not shown). However,
similar to the data presented in Figure 5, we observed reduced
PD1+ 2H6 CD4+ T cells, both TCRVb14- and TCRVb14+ in the
recipients infused with 2H6 T cells, regardless of the source of B
cells (Figures 6I–J). Resembling the ex-vivo results shown inFigure
1, we demonstrated that co-transfer of 2H6 CD4+ T cells and
VH125 B cells led to the reduction of activated CD4+ T cells
expressing CD69 compared to the other recipient groups (Figures
6K, L). Overall, our results suggest that the 2H6 CD4+ T cells can
alter the phenotype and functionofVH125B cells leading to amore
tolerogenic environment.Frontiers in Immunology | www.frontiersin.org 10DISCUSSION
In this study, we report the regulation of pathogenic insulin-
reactive VH125 B cells by insulin-reactive 2H6 T cells promoting
tolerance, and protecting NOD mice from T1D development.
2H6 T cells mediate this protection by reducing the insulin-
reactive B cell populations and their ability to bind insulin.
Furthermore, the 2H6 T cells downregulate the expression of
MHC and costimulatory molecules on insulin-reactive B cells
and alter germinal center interactions. In addition, 2H6 T cells
influence insulin antigen, protein and peptide presentation by
VH125 B cells from 2H6VH125 mice and result in weaker T cell
proliferation compared to the VH125 B cells from VH125 mice,A B D
E F G
I
H
J K L
C
FIGURE 6 | 2H6 T cells reduce VH125 B cells interactions in vivo in Rag-deficient NODmice. 4-week-old Rag-/-NODmice were adoptively transferred i.v.with 3 × 106
CD4+ T cells together with B cells in a 1:1 ratio, using 8-week-old donor NOD, 2H6 NOD and VH125 NODmice. 4 weeks post-transfer, splenocytes and cells from the
pancreas draining lymph nodes (PLN) were harvested from 8-week-old mice and stained using antibodies for flow cytometry. (A)% of Insulin-reactive B cells gated from
CD19+B220+TCRb- live single cells. % Insulin-reactive B cells expressing PNA and GL7 (B), PDL1 (C), CD40 (D), CD80 (E), and CD86 (F), gated from (A). Sera from the
same mice were used to measure total class-switched IgG (G) and total insulin-reactive IgG (H) by ELISA. (I)%CD4+PD1+ T cells was gated on live single CD19-CD8- cells
with the same gating applied to CD4+PD1+TCRVbeta14+ T cells shown in (J). (K)%CD4+CD69+ T cells in total CD4+ T cells (K) and TCRVbeta14+CD4+ T cells (L). Data
were generated from nine individual mice pooled from two independent experiments. Data from left to right: NOD B and NOD T, NOD B and 2H6 T, VH125 B and NOD T,
VH125 B, and 2H6 T are shown in this order in each plot. Data from NOD B and NOD T cell recipient Rag-/-NODmice are shown as a non-transgenic mouse comparison.
Data were assessed for significance using multiple T tests and FDR correction. **P < 0.001, ***P < 0.0001.November 2020 | Volume 11 | Article 585886
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proliferation is associated with greatly enhanced TGFb secretion.
It would be of interest, in experiments in the future, to test
whether the changes induced in VH125 B cells result in
subsequent suppression of pathogenic insulin-reactive T cells.
In vivo, most antigen-specific T-B cell interactions take place in
germinal centers and germinal center B cells in 2H6VH125 mice
have a significantly reduced expression of PDL1, which was
mirrored by reduced PD1 expression on the 2H6 T cells in these
mice compared to the NOD mice carrying only VH125 BCR or
2H6 TCR, respectively. The PD1-PDL1 axis is important to keep
the host’s immune response in check and inhibition of PD1-
PDL1 enhances T cell function. The reduction of PD1 and PDL1
expression may explain the suppressive effect of 2H6 T cells on
insulin-reactive B cells and the elevation of the immune-
regulatory cytokine TGFb secretion. Interestingly, IgG
antibodies were higher in 2H6VH125 NOD mice than in
VH125 NOD mice, suggesting that these 2H6 T cells promote
class switching in the insulin-reactive B cells, which has not
previously been reported. The class switching is also supported
by up-regulation of aicda, tgfbr1, and il6 gene expression. Taking
an adoptive transfer approach, we were able to confirm the
findings in Rag-/-NOD hosts. Our results provide evidence that
insulin-reactive and TGFb-secreting 2H6 regulatory T cells play
a dominant role in modulating insulin-reactive pathogenic B
cells. This change in the insulin-reactive B cells to a more
tolerogenic phenotype could be tested in the future by co-
transfer with pathogenic insulin-reactive T cells to the Rag-/-
NOD hosts.
Germinal centers are pivotal to the generation of an antigen-
specific immune response and are specialized sites in peripheral
lymphoid tissues where T:B cell interaction take place. IL-21 is an
important cytokine for germinal center formation (35), and is
required for the development of T1D in NOD mice (36, 37).
Interestingly, the overexpression of IL-21 in pancreatic b cells of
C57BL/6 mice resulted in islet destruction and the development
of spontaneous T1D in a normally diabetes-resistant C57BL/6
mouse strain (37). The significant reduction of circulating IL-21
in the 2H6VH125 NOD mice in our study further supports the
role of IL-21 in the immunopathogenesis of T1D development.
In line with the reduction of IL-21, our study also revealed a
reduction of the germinal center B cells and reduced ability of
germinal center B cell to interact with Tfh cells in the 2H6VH125
NOD mice, due to the presence of the 2H6 T cells. The reduction
was likely mediated by the combination of reduced expression of
costimulatory molecules on insulin-reactive B cells, reduced
insulin binding by VH125 BCR and an altered cytokine
environment, namely lower IL-21 and higher TGFb .
Interestingly, IL-21 can also alter costimulation on B cells (38),
and thus, the lower IL-21 may have directly resulted in reduced
expression of costimulatory molecules in the B cells of 2H6VH125
NOD mice. These changes on B cells can in turn affect T cell
function, which include less proliferation in response to the
cognate antigen presented by the B cells, as seen in 2H6VH125
NOD mice. Our studies are interesting in the light of findings that
patients with T1D have increased IL-21 and Tfh cells in the bloodFrontiers in Immunology | www.frontiersin.org 11compared to healthy controls, particularly in children who were
positive for multiple autoantibodies prior to T1D diagnosis (39,
40). Furthermore, a longitudinal study assessing the transition of
naïve CD4+ T cells to activated memory autoreactive T cells from
the blood of infants found that increases in IL-21 and Tfh gene
signatures were associated with later development of b cell
autoimmunity in children (41, 42).
In our study, we found that the insulin-reactive regulatory
2H6 cells reduced the proportion of Tfh cells and altered the
germinal center B cells. In comparison, Wan and colleagues
recently reported the interaction of insulin-reactive pathogenic
CD4 T cells with VH125 B cells, and the authors found increased
Tfh cells and germinal center B cells, which enabled the mice to
develop T1D (27). Our results together with the results of Wan
and colleagues suggest that antigen-specific T:B cell interactions
are vital for both the protection from and promotion of T1D
development and that the endpoint is determined by the nature
of the T cells, i .e., regulatory vs. pathogenic, which
predominantly interact with the germinal center B cells.
However, our results additionally showed that the B cells will,
in turn, affect T cell functions. Interestingly, when the pathogenic
insulin-reactive 8F10 TCR transgene and VH125 BCR transgene
are both present, the B cells are able to class switch to IgG
subtypes of both insulin-specific autoantibodies and non-
insulin-specific antibodies (27). However, the authors used a
site directed VH125 transgene that allows class switching,
whereas the insulin-reactive BCR, VH125, used in our study is
an IgMa transgene, which usually prevents class switching. The
presence of regulatory 2H6 T cells in our study also promotes
IgG class switching in predominantly non-insulin specific
antibodies; however, as the VH125 mice we studied were not
on a Rag-deficient background, it is likely these class-switched
antibodies were potentially due to escaping B cells that failed to
express the VH125 BCR (<5% B cells). This may also contribute
to T1D prevention, and thus further investigation will be
undertaken in the future.
In conclusion, we have demonstrated that a regulatory
insulin-specific T cell promotes tolerance in an insulin-specific
B cell, by decreasing T:B cell interactions, but enhancing TGFb
secretion. Uniquely, the presence of 2H6 promotes B cells from
the VH125 transgenic mouse to undergo class switching to non-
insulin specific IgG, a previously unreported phenomenon, and
this may also aid in protecting NOD mice from T1D
development. Our study also identifies the down regulation of
costimulation and antigen presentation function of insulin-
reactive B cells by 2H6 T cells, which counter-regulate the
insulin-reactive T cells. Our study further illustrates the
importance of enhancing antigen-specific T cell regulation, and
the knowledge gained in this study may aid better therapeutic
strategies in prevention or treatment of T1D.DATA AVAILABILITY STATEMENT
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and diabetes development. (A) Female mice were monitored for glycosuria weekly,
from 12 weeks of age, for spontaneous diabetes development, with diabetes
confirmed with a blood glucose >250mg/dl. (B) Pancreata from 12-week old female
NOD, 2H6, VH125 and 2H6VH125 NODmice were assessed for immune infiltration
from 127, 44, 111, 191 islets respectively (n=9, 4, 11, 11 mice respectively). The
insulitis was scored by the percentage of infiltration in each observed islet. Data was
assessed for significance using individual Chi-square tests (A) or Log-rank (Mantel-
Cox) test (B). **p < 0.01, ***p < 0.0001.
SUPPLEMENTARY FIGURE 2 | 2H6 T cells can alter total B cell populations.
Splenocytes (and pancreas draining lymph nodes (PLN)) were harvested from 8-
week-old mice, including the heavy and light chain insulin-specific BCR transgenic
NOD mouse (125tg) and stained using antibodies for flow cytometry. (A) Absolute
cell number from the Spleen and PLN. (B) Representative flow staining of insulin-
reactive B cells identified by binding to insulin-FITC gated from live single CD19
+B220+TCRb- B cells; (C) % of Insulin-reactive B cells summarized from B. (D) %
Follicular B cells gated on CD19+B220+CD21+CD23+ cells from live single TCRb-
cells and (E)%marginal zone B cells gated on CD21+CD23- from the same gate as
D. (F) Mean Fluorescent Intensity (MFI) of MHCII (IAg7) gated within the total B cell
population. G-I; % of CD19+B220+ B cells expressing CD40 (G), CD80 (H), and
CD86 (I) gated as in B. Data were generated from 9-10 individual mice, pooled from
3-5 independent experiments. Data left to right: NOD, 2H6, VH125, 2H6VH125 are
shown in this order in each plot. Data from NOD mice are shown as a non-
transgenic mouse comparison. Data were assessed for significance using multiple T
tests and FDR correction. **P < 0.001, ***P < 0.0001.
SUPPLEMENTARY FIGURE 3 | 2H6 TCR transgene promotes IgG class
switching in VH125 B cells. Sera from 8-week old mice were tested for IgG1 (A),
IgG2a (B), IgG2b (C), IgA (D) and insulin-specific autoantibodies of the same
isotypes (E-H). Data were generated from 9-10 individual mice, pooled from 2
independent experiments. Data left to right: NOD, 2H6, VH125, 2H6VH125 are
shown in this order in each plot. Data from NOD mice are shown as a non-
transgenic mouse comparison. Data were assessed for significance using multiple
T tests and FDR correction. **P < 0.001, ***P < 0.0001.
SUPPLEMENTARY FIGURE 4 | 2H6 T cells promote IgG class switching in
VH125 B cells in vivo in Rag-deficient NODmice. 4-week-old Rag-/-NODmice were
adoptively transferred i.v. with 3x106 CD4+ T cells co-transferred in a 1:1 ratio with
B cells using 8-week-old donor NOD, 2H6 NOD and VH125 NOD mice. 4 weeks
post-transfer sera were tested for IgG1 (A), IgG2a (B), IgG2b (C), IgA (D) and
insulin-specific autoantibodies of the same isotypes (E-H). Data were generated
from 9-10 individual mice, pooled from 2 independent experiments. Data left to
right: NOD, 2H6, VH125, 2H6VH125 are shown in this order in each plot. Data from
NOD B and NOD T recipient mice are shown as a non-transgenic mouse
comparison. Data were assessed for significance using multiple T tests and FDR
correction. **P < 0.001, ***P < 0.0001.REFERENCES
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